Search research articles
Contact Us
Filters
Showing results (61-70 of 170) with videos related to
Page
of 17
Sort By:
European Journal of Haematology
|
January 11, 2020
Obinutuzumab and venetoclax induced complete remission in a patient with ibrutinib-resistant non-nodal leukemic mantle cell lymphoma
Xiang Zhou, Maximilian Johannes Steinhardt, Johannes Düll, et al.
Microbiology Spectrum
|
December 13, 2023
Lymphocyte and neutrophil count combined with intestinal bacteria abundance predict the severity of COVID-19
Liuying Chen, Zhongwei Yin, Dan Zhou, et al.
International Journal of Immunopathology and Pharmacology
|
December 23, 2020
Sequential CD38 monoclonal antibody retreatment leads to deep remission in a patient with relapsed/refractory multiple myeloma
Maximilian Johannes Steinhardt, Xiang Zhou, Franziska Krummenast, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 23, 2026
European Expert Recommendations on Teclistamab Management for Relapsed or Refractory Multiple Myeloma
Paula Rodríguez-Otero, Philippe Moreau, Maria Victoria Mateos, et al.
European Journal of Radiology
|
August 26, 2022
Multi-parametric whole-body MRI evaluation discerns vital from non-vital multiple myeloma lesions as validated by <sup>18</sup>F-FDG and <sup>11</sup>C-methionine PET/CT
Anke Heidemeier, Wiebke Schloetelburg, Annette Thurner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 1, 2016
A GRP78-Directed Monoclonal Antibody Recaptures Response in Refractory Multiple Myeloma with Extramedullary Involvement
Leo Rasche, Emmanuelle Menoret, Valentina Dubljevic, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 13, 2021
Improved Primary Staging of Marginal-Zone Lymphoma by Addition of CXCR4-Directed PET/CT
Johannes Duell, Franziska Krummenast, Andreas Schirbel, et al.
Clinical and Experimental Medicine
|
October 7, 2023
Does medication-related osteonecrosis of the jaw affect survival of patients with Multiple Myeloma?: Exploring a large single center database using artificial intelligence
Max Bittrich, Regina Hetterich, Antonio G Solimando, et al.
Blood Cancer Discovery
|
September 4, 2025
Timing genomic antigen loss in multiple myeloma treated with T-cell redirecting immunotherapies
Marios Papadimitriou, Sungwoo Ahn, Benjamin T Diamond, et al.
Cancer Medicine
|
December 8, 2025
Talquetamab-Related Dysgeusia in Multiple Myeloma Compared to BCMA-Targeted Bispecifics and High-Dose Melphalan
Anna Fleischer, Magdalena Roll, Jan H Frenking, et al.
Page
of 17
Search research articles
Search
Showing results (61-70 of 170) with videos related to
Sort By:
Page
of 17
European Journal of Haematology
|
January 11, 2020
Obinutuzumab and venetoclax induced complete remission in a patient with ibrutinib-resistant non-nodal leukemic mantle cell lymphoma
Xiang Zhou, Maximilian Johannes Steinhardt, Johannes Düll, et al.
Microbiology Spectrum
|
December 13, 2023
Lymphocyte and neutrophil count combined with intestinal bacteria abundance predict the severity of COVID-19
Liuying Chen, Zhongwei Yin, Dan Zhou, et al.
International Journal of Immunopathology and Pharmacology
|
December 23, 2020
Sequential CD38 monoclonal antibody retreatment leads to deep remission in a patient with relapsed/refractory multiple myeloma
Maximilian Johannes Steinhardt, Xiang Zhou, Franziska Krummenast, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 23, 2026
European Expert Recommendations on Teclistamab Management for Relapsed or Refractory Multiple Myeloma
Paula Rodríguez-Otero, Philippe Moreau, Maria Victoria Mateos, et al.
European Journal of Radiology
|
August 26, 2022
Multi-parametric whole-body MRI evaluation discerns vital from non-vital multiple myeloma lesions as validated by <sup>18</sup>F-FDG and <sup>11</sup>C-methionine PET/CT
Anke Heidemeier, Wiebke Schloetelburg, Annette Thurner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 1, 2016
A GRP78-Directed Monoclonal Antibody Recaptures Response in Refractory Multiple Myeloma with Extramedullary Involvement
Leo Rasche, Emmanuelle Menoret, Valentina Dubljevic, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 13, 2021
Improved Primary Staging of Marginal-Zone Lymphoma by Addition of CXCR4-Directed PET/CT
Johannes Duell, Franziska Krummenast, Andreas Schirbel, et al.
Clinical and Experimental Medicine
|
October 7, 2023
Does medication-related osteonecrosis of the jaw affect survival of patients with Multiple Myeloma?: Exploring a large single center database using artificial intelligence
Max Bittrich, Regina Hetterich, Antonio G Solimando, et al.
Blood Cancer Discovery
|
September 4, 2025
Timing genomic antigen loss in multiple myeloma treated with T-cell redirecting immunotherapies
Marios Papadimitriou, Sungwoo Ahn, Benjamin T Diamond, et al.
Cancer Medicine
|
December 8, 2025
Talquetamab-Related Dysgeusia in Multiple Myeloma Compared to BCMA-Targeted Bispecifics and High-Dose Melphalan
Anna Fleischer, Magdalena Roll, Jan H Frenking, et al.
Page
of 17